Evidence map›Paper›PMID 38277039›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

The regulatory effects of mesedin and beditin alpha2-adrenoblockers on the functional activity of the nervous, cardiovascular, and endocrine systems in rats under the hypoxic conditions.

Ashkhen L Manukyan, Magdalina M Melkonyan, Lilit M Sukiasyan, Svetlana O Vardanyan, Lilit S Hunanyan, Konstantin B Yenkoyan, Seda H Harutyunyan

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. αImmunologic research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ashkhen L ManukyanDepartment of Medical Chemistry, Yerevan State Medical University After M. Heratsi, Koryun 2, 0025, Yerevan, Armenia. manukyanashkhen@mail.ru.ORCID http://orcid.org/0000-0003-2608-5295
Magdalina M MelkonyanDepartment of Medical Chemistry, Yerevan State Medical University After M. Heratsi, Koryun 2, 0025, Yerevan, Armenia.
Lilit M SukiasyanLaboratory of Morphological Studies, SRS, Yerevan State Medical University After M. Heratsi, 0025, Yerevan, Armenia.
Svetlana O VardanyanScientific-Technological Center of Organic-Pharmaceutical Chemistry of NAS RA, Institute of Fine Organic Chemistry After A.L. Mnjoyan, 0014, Yerevan, Armenia.
Lilit S HunanyanDepartment of Medical Chemistry, Yerevan State Medical University After M. Heratsi, Koryun 2, 0025, Yerevan, Armenia.
Konstantin B YenkoyanNeuroscience Laboratory, Cobrain Center, Yerevan State Medical University After M. Heratsi, 0025, 2 Koryun Str., Yerevan, Armenia.
Seda H HarutyunyanScientific-Technological Center of Organic-Pharmaceutical Chemistry of NAS RA, Institute of Fine Organic Chemistry After A.L. Mnjoyan, 0014, Yerevan, Armenia.
Yerevan State Medical University · AMInstitute of Fine Organic Chemistry of Scientific - Technological Center of Organic and Pharmaceutical Chemistry · AM

Funding

State Committee of Science RA N 10-14/I-1
6 · The paper itself

Abstract

One of the reasons of the development of pathologies causing death is hypoxia. The purposes of this study were (1) to study some physiological and biochemical mechanisms of α

Indexed as

Adrenergic alpha-2 Receptor AntagonistsCardiovascular SystemHypoxiaAnimalsBlood PressureCorticosteroneHemodynamicsMaleOxygenRatsRats, WistarReceptors, Adrenergic, alpha-2Vascular ResistanceAdrenergic alpha-2 Receptor AntagonistsCorticosteroneOxygenReceptors, Adrenergic, alpha-2Hypoxiaα2-Adrenoblockersα2-Adrenoceptors

Identifiers

PMID38277039
OpenAlexW4391259701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.